66
Gastrointestinal Bleeding 2012

Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Embed Size (px)

Citation preview

Page 1: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Gastrointestinal Bleeding

2012

Page 2: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Pathophysiology of GI Bleeding

• Mucosal lesions– Acid-peptic disease, drug-induced (NSAIDs),

Infectious (H. pylori), inflammatory bowel dz

• Portal hypertension– Esophageal varices, hypertensive gastropathy

• Coagulopathy - Hemophilia, hepatic coagulopathy, CHF w/hepatic congestion

• Vascular lesions - hemangiomas

Page 3: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Sources of GI Bleeding

• Upper GI Tract• Proximal to the Ligament of Treitz• 70% of GI Bleeds

• Lower GI Tract• Distal to the Ligament of Treitz• 30% of GI Bleeds

Page 4: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory
Page 5: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory
Page 6: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Incidence

• Upper GI bleed 100/100,000 Above the ligament of Treitz• Lower GI Bleed 20/100,000 Below the ligament of Treitz• Both are more common in males and elderly.

Page 7: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Causes of Upper GI Bleed

• 1) Peptic ulcer disease - most common cause A) duodenal ulcers 29% will rebleed in 10% of cases within 24-48h B) gastric ulcers 16% more likely to rebleed C) stomal ulcers <5%

Page 8: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Causes of Upper GI Bleed

• 2) Erosive gastritis, esophagitis, duodenitis some causes are ETOH, ASA, NSAID’s• 3) Esophageal and gastric varices causes by portal hypertension• 4) Mallory-Weiss syndrome – longitudinal mucosal tear in the cardioesophageal region caused by repeated retching

Page 9: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Causes of Upper GI Bleed

• 5) stress ulcers• 6) arteriovenous malformation• 7) malignancy• 8) aortoenteric fistula

Page 10: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Causes of Lower GI Bleeding

• 1) Hemorrhoids - most common cause• 2) Diverticulosis – common, painless, and can be massive Caused from an erosion into a penetrating artery from the diverticulum.• 3) Arteriovenous malformations – common and seen in people with hypertension and aortic stenosis

Page 11: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Causes of Lower GI Bleeding

• 4) CA/polyps• 5) inflammatory bowel disease • 6) infectious gastroenteritis• 7) Meckel diverticulum

Page 12: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

History

– HPI• Hematemesis (coffee grounds vs. bright red)• Hematochezia• Melena - dark, tarry stool• Pain symptoms

– PMHx• ulcer disease, joints, skin

– Social Hx• EtOH

– Medications• NSAIDs, steroids, ASA, Plavix, Coumadin, Lovenox, Heparin, Iron

Page 13: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Physical Exam Including:• HR, BP, tilt test, RR, O2 saturation• General appearance, Mental status• Neck veins, oral mucosa• Skin temperature and color• Abdominal exam• Rectal• Stigma of Cirrhosis• NG Tube findings (upper vs. lower g.i. source)• Urine output

Page 14: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Work Up• Labs

• CBC• Serial HgB• Platelets

• BMP• BUN, Cr

• Type and Crossmatch• Coagulation studies• Stool WBCs to eval for infectious etiol• Imaging studies?

Page 15: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Localization of Bleeding

• History• NG Tube• EGD• Colonoscopy• Tagged RBC Scan• Angiography

Page 16: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Upper GI Bleed• 50% present with hematemesis

• NGT with positive blood on aspirate

• 11% of brisk bleeds have hematochezia

• Melena (black tarry stools)—this develops with approximately 150-200cc of blood in the upper GI tract. – Stool turns black after 8 hours of sitting within the gut.

• 50% present with hematemesis

• NGT with positive blood on aspirate

• 11% of brisk bleeds have hematochezia

• Melena (black tarry stools)—this develops with approximately 150-200cc of blood in the upper GI tract. – Stool turns black after 8 hours of sitting within the gut.

Page 17: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Upper GI Bleed

• Risk Factors• NSAID use• H. pylori infection• Increased age

• Upper GI Bleeding accounts for approximately 350,000 hospitalizations per year.

Page 18: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Upper GI Bleed

• Etiology of Upper Bleeds• Duodenal Ulcer-30%• Gastric Ulcer-20%• Varices-10%• Gastritis and duodenitis-5-10%• Esophagitis-5%• Mallory Weiss Tear-3%• GI Malignancy-1%• Dieulafoy Lesion• AV Malformation-angiodysplasia

Page 19: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Duodenal Ulcer

Page 20: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Varices

Page 21: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Esophagitis

Page 22: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

GI Malignancy

• Esophageal Tumor

Page 23: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

GI Malignancy

• Gastric Carcinoma

Page 24: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Angiodysplasia

Page 25: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Lower GI Bleed

• Acute LGIB: <3d• Chronic LGIB: > several days• Hematochezia• Blood in Toilet• Clear NGT aspirate• Normal Renal Function• Usually Hemodynamically stable

– <200ml : no effect on HR**– >800ml: SBP drops by 10mmHg, Hr increases by 10– >1500ml: possible shockOR– 10% Hct: tachycardia*– 20% Hct: orthostatic hypotension– 30% Hct: shock

Stops spontaneously (80 - 85% of the time)

Page 26: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Lower GI Bleed

• Etiology of hematochezia• Diverticular-17-40%• Angiodysplasia-9-21%• Colitis (ischemic, infectious, chronic IBD, radiation injury)-2-30%• Neoplasia, post-polypectomy-2-26%• Anorectal Disease (including rectal varices)-4-10%• Upper GI Bleed-0-11%• Small Bowel Bleed-2-9%

Barnet J and H Messmann H. Nat Rev Gastroenterol Hepatol 6, 637-646 (2009).

Page 27: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Diverticulosis

Page 28: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Diverticulitis-NOT A CAUSE OF GI BLEEDING

Page 29: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Colonic Polyps

Page 30: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Malignancy

• Colon Carcinoma

Page 31: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Hemmorrhoids

Page 32: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Management of GI Bleed

• Oxygen• IV Access-central line or two large bore

peripheral IV sites• Isotonic saline for volume resuscitation• Start transfusing blood products if the patient remains unstable despite

fluid boluses.

• Airway Protection• Altered Mental Status and increased risk of aspiration with massive upper

GI bleed.

Page 33: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Management of GI Bleed

• ICU admit indications• Significant bleeding (>2u pRBC) with hemodynamic instability

• Transfusion• Brisk Bleed, transfusing should be based on hemodynamic status, not lab

value of Hgb.• Cardiopulmonary symptoms-cardiac ischemia or shortness of breath,

decreased pulse ox

• 1 unit PRBC increases Hgb by 1mg/dL and increase Hct by 3%• FFP for INR greater than 1.5• Platelets for platelet count less than 50K

Page 34: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Basic Admission Orders

• Admit to ICU/intermediate care/telemetry s/o …• Dx: Upper/Lower G.I. Bleed• Condition:• VS:• Allergies:• Activity: Bedrest• Nursing: Is/Os, ? Foley• Diet: NPO

Page 35: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Basic Admission Orders (Cont.)

• IVF: NSS @ ?cc/h• Medications: I.V. Protonix, convert

medications to i.v., hold anti-hypertensives• Labs: serial H/H, type and cross, coags, Chem

7, LFTs• Consults: GI, +/- Surgery

Page 36: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Obscure GI Bleed

• Present: Fe Defic anemia• Etiology:

– Younger than 40• Tumors• Meckel’s diverticulum• Dieulafoy’s lesion• Crohn’s Disease• Celiac Disease

– Greater than 40• Angioectasia• NSAID enteropathy• Celiac

Gerson LB. Clin Gastroenterol & Hepatol 2009;7:828-833.

Page 37: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Obscure GI Bleed

• Work Up– EGD, Colonoscopy both neg– Repeat – CE, PE or DE,– angiography

Page 38: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

PillCam SB Latest Generation

PillCam SB

– 11 mm x 26 mm

– 1 camera

– 2 frames per second

– Std optics / 1 lens

– Standard lighting control

– Standard angle of view (AOV) 140°

– Depth of field 0-30 mm

PillCam SB 2

– 11 mm x 26 mm

– 1 camera

– 2 frames per second

– New optics / 3 lenses

– Advanced Automatic Light Control

– Extra wide angle of view (AOV) 156°

– Depth of field 0-30 mm

Page 39: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Image Spectrum: PillCam Capsule Endoscopy

Bleeding

Celiac DiseaseTumors

Suspected Crohn’s

Page 40: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

References

• Harrison’s Principles of Internal Medicine 14th edition• Gastrointestinal Atlas.com endoscopy photos• Pocket Medicine, 3rd edition• Barnet J and H Messmann H. Diagnosis and management of lower gastrointestinal bleeding. Nat Rev Gastroenterol Hepatol

6, 637-646 (2009).• Gerson LB. Recurrent Gastrointestinal Bleeding After Negative Upper Endoscopy and Colonoscopy. Clin Gastroenterol &

Hepatol 2009;7:828-833.• Melmed GY and Simon KL. Capsule Endoscopy: Practical Applications. Clin Gastrolenterol & Hepatology 2005;3:411-422.• AGA Institute. AGA Institute Medical Position Statement on Obscure Gastrointestinal Bleeding. Gastroenterology

2007;133:1694-1696.

Page 41: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

THE END

Page 42: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Peptic Ulcer Disease

Page 43: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Epidemiology

• 10% US population >17 years of age have peptic ulcer disease at some time.

• White Americans have a 10% prevalence of H. pylori by age 35 and 80% by age 75.

• Black Americans have a 45% prevalence of H. pylori by age 25.

Page 44: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Pathophysiology

• Prostaglandins produce mucous and bicarbonate ions which protect the tissue in the stomach by being destroyed with hydrochloric acid and pepsin.

• Dyspepsia is the imbalance between the protective mucosa and acid/pepsin.

• Peptic ulcer which is a defect beyond muscularis mucosa will develop if there is an imbalance.

• Note -stress ulcers do not extent through the muscularis mucosa.

Page 45: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Pathophysiology

• Two types of peptic ulcers 1) Duodenal ulcers which occur in the

first portion of the duodenum. 2) Gastric ulcers which usually occur in

the lesser curvature of the stomach.

Page 46: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Causes

• H. pylori - a spiral, urease producing flagellated bacterium which lives between the mucus gel and mucosa. Its production of urease, cytotoxins, proteases and other compounds disturb the gel and increase tissue exposure to acid and pepsin.

• H. pylori is seen in 95% of patients with duodenal ulcers and 80% of gastric ulcers.

• Note only 10-20% of patients who are infected with H. pylori will develop ulcers.

Page 47: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Causes

• NSAID’s - inhibit prostaglandins which in turn increases tissue exposure to acid and pepsin.

• Zollinger-Ellison syndrome - is a gastrin secreting tumor which creates such a high acid level it over rides the protective gel.

• Cigarette smoking - inhibits bicarbonate ion production and increases gastric emptying.

Page 48: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Causes

• Bile salts• Emotional stress• Type O blood• Prolonged use of corticosteriods• Caffeinated beverages• Note diet and alcohol are not

predisposing factors to the development of peptic ulcers.

Page 49: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Clinical Features

• Epigastric pain - (gnawing, aching or burning) is the main complaint.

• Gastric ulcers usually develop pain shortly after eating.

• Duodenal ulcers usually develop pain 2-3 hours after eating and awaken patients at night. Pain can be relieved by food.

• Physical exam of uncomplicated PUD, there may be a finding of epigastric tenderness.

Page 50: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Diagnosis

• Definite diagnosis can only be made by visualization with an upper GI or endoscopy.

• Endoscopy has the advantage of being able to take a biopsy which is definitely needed for gastric ulcers to rule out malignancy.

Page 51: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Diagnosis• Several ways to determine H. pylori infection• 1) invasive a) during endoscopy a rapid urease test, histologic study, or culture can be done.• 2) noninvasive a) serologic studies which can not be done as a follow up for cure due to antibodies being positive for several years after eradication of infection. b) urea breath test can be used to confirm cure. c) stool antigens test can also be used to confirm cure.

Page 52: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Treatment

• Stop any offending agents such as NSAID’s.

• Bland diets with frequent feedings has not been shown to be effective.

Page 53: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Treatment• Antacids – neutralize gastric acids. a) good for acute pain relief and healing ulcers. b) poor compliance due frequency of doses. c) inhibit absorption of some drugs such as warfarin, digoxin, some anticonvulsants and antibiotics. d) aluminum causes constipation and should not be given with renal failure patients due to accumulation which can cause osteoporosis and encephalopathy. e) magnesium causes diarrhea.

Page 54: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Treatment• H2- Antagonists – inhibit gastric acid secretion a) equally as effective as antacids with better compliance due to decreased frequency of doses. b) cimetidine inhibits cytochrome p450 system greater than other H2-antagonists which will cause an increase in drugs such as warfarin, phenytoin, diazepam, TCA’s, propranolol, etc. c) renal excretion and therefore must adjust doses in patients with renal disease.

Page 55: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Treatment• Proton Pump Inhibitors - inhibit gastric acid

secretion a) heal ulcers faster then H2-antagonists and antacids. b) omeprazole has also been shown to affect the cytochrome p450 system. c) lansoprazole does not affect other drug metabolism. d) pantoprazole has been shown to decrease bleeding from peptic ulcers.

Page 56: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Treatment

• Sulcralfate – locally binds to the base of the ulcer and therefore protects it from acid

a) Also has been shown to absorb bile acids, inhibit pepsin activity, and increase prostaglandin production. b) Needs an acidic environment to work therefore not beneficial to give antacids c) Causes constipation, dry mouth and inhibits the absorption of many medications.

Page 57: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Treatment

• Misoprostol – prostaglandin E1 analogue which acts as natural prostaglandin in the body

a) Only indicated for prevention of NSAID -induced gastric ulcers in high risk patients. b) contraindicated in pregnant women and women in childbearing age because it causes spontaneous abortion. c) can cause diarrhea and crampy abdominal pain.

Page 58: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Treatment

• Bismuth compounds – decrease pepsin activity, increase mucus secretion, form a barrier protection on ulcers, augment prostaglandin synthesis, slow hydrogen ion diffusion across mucosal barrier, and H. pylori bactericidal effect.

a) Used in triple drug combinations for the treatment of H. pylori.

Page 59: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Treatment

• If H. pylori positive then must be given antibiotics to prevent recurrence of ulcer.

• Usually done with triple or quadruple treatment regimens.

• Some antibiotics in regimens are metronidazole, tetracycline, amoxicillin, clarithromycin.

Page 60: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Complications of PUD

• GI bleeding is the most common complication of PUD and the most common cause of upper GI bleeding.

• Please see previous lecture on management of GI Bleeding.

Page 61: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Complications of PUD Perforation • Initially a chemical peritonitis develops which then progresses

to a bacterial peritonitis. • Anterior perforation - patients will have sudden abdominal

pain with guarding and rebound. 60-70% will demonstrate free air of x-rays.

• Posterior perforation - patients will develop back pain with no free air on x-ray and may mimic pancreatitis but lipase will be normal or only slightly elevated.

• No free air on x-rays cannot rule our perforation.• IV fluids, electrolyte corrections, NG tube, broad spectrum

antibiotics and surgery.

Page 62: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Complications of PUD Gastric outlet obstruction• Scaring from healed ulcers or edema from active ulcer with

development of obstruction.• Obstruction will cause gastric dilation, vomiting, dehydration,

metabolic alkalosis.• Patients will develop upper abdominal pain with vomiting,

early satiety, weight loss, succussion splash.• Abdominal x-ray will show dilated stomach shadow with large

air-fluid level. • IV fluids, electrolyte corrections, NG tube, and surgery if

needed.

Page 63: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Questions

• The most common cause of a lower GI bleed is?

A) Diverticulosis B) Cancer C) Hemorrhoids D) AV malformations

Page 64: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Questions

• 2) Colonoscopy is diagnostic and therapeutic and is more accurate than bleeding scans and angiography for GI bleeds.

T/F• 3) Only 40% of patients who are infected with

H. pylori will develop ulcers. T/F

Page 65: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Questions

• 4) Treatment of ulcers which are positive for H. pylori need?

A) only a longer coarse of PPI B) addition of antibiotics C) need an inpatient coarse of treatment D) can be treated the same as ulcers that are negative for H. pylori

Page 66: Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Answers

• 1) C• 2) T• 3) F• 4) B